Form 4 for BVS Bioventus Inc.
Accepted 2021-09-10 00:00:00 ET · period of report 2021-09-09 · accession 0000899243-21-035518 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-10 | 2021-09-09 | BVS | Reali Kenneth Michael | CEO, Dir | P - Purchase | $14.81 | +1,800 | 11.2K | +19% | +$26.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-09-09 | P | A | 1,800 | $14.81 | 11,175 | D | — | — |